BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of a colorimetric micromethod for determining the minimal inhibitory concentration of antibiotics against Mycobacterium tuberculosis]. 2006

M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
Laboratorio de Referencia del Programa de Control de la Tuberculosis de la Provincia de Buenos Aires, Argentina.

Multidrug-resistant tuberculosis (MDR) caused by strains resistant to both isoniazid and rifampin is now considered a serious sanitary problem worldwide. New technical tools for the early detection of these strains are urgently needed to avoid their spread within the community. We have evaluated a microplate colorimetric-based method to determine the minimal inhibitory concentration (MIC) of first-line antituberculosis drugs by using 3-(4, 5 dimethylthiazolyl 1-2 yl)-2,5 diphenyl tetrazolium bromide as a bacterial growth indicator (MTT) (M-MTT). A total of 603 clinical isolates, 507 from respiratory cases (84.1%) and 96 from non-respiratory cases (15.9%) were processed. The proportion method on a Löwenstein-Jensen medium (PM) with isoniazid (INH), 0.20 microg/ml; streptomycin (SM), 4.00 microg/ml; ethambutol (EMB), 2.00 microg/ml and rifampin (RMP), 40.00 microg/ml, was used as the gold standard. The drugs and the concentration range tested were: INH, 1.00-0.03 microg/ml; SM, 8.00-0.25 microg/ml; EMB, 32.00-1.00 microg/ml and RMP, 2.00-0.06 microg/ml. MIC results were obtained on an average of 8 days (range: 7-12). The cut-off values for each drug, calculated by the ROC curve method, were: INH, 0.25 microg/ml, RMP, 0.50 microg/ml, SM, 4.00 microg/ml and EMB, 4.00 microg/ml. Sensitivity and specificity for RMP were 100 %, while for INH, they were 97.8% and 99.5% respectively. The results obtained suggested that M-MTT is a low cost and easy to set up method that could be applied to MDR clinical diagnosis in developing countries.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001431 Bacteriological Techniques Techniques used in studying bacteria. Bacteriologic Technic,Bacteriologic Technics,Bacteriologic Techniques,Bacteriological Technique,Technic, Bacteriological,Technics, Bacteriological,Technique, Bacteriological,Techniques, Bacteriological,Bacteriologic Technique,Bacteriological Technic,Bacteriological Technics,Technic, Bacteriologic,Technics, Bacteriologic,Technique, Bacteriologic,Techniques, Bacteriologic

Related Publications

M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
[Use of paper indicator discs for determining the minimal inhibitory concentration of antibiotics].
May 1979, Antibiotiki,
M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
Evaluation of the Titertek Multiskan for determining minimal inhibitory concentration endpoints.
July 1982, Antimicrobial agents and chemotherapy,
M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis drugs against Mycobacterium tuberculosis isolates.
June 2016, Memorias do Instituto Oswaldo Cruz,
M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
[Determination of antibiotic minimal inhibitory concentration using a micromethod].
November 1972, Pathologie-biologie,
M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
[Factors influencing the minimal inhibitory concentration of rifampicin for Mycobacterium tuberculosis (author's transl)].
October 1973, Kekkaku : [Tuberculosis],
M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
[Determination of the minimal inhibiting concentration of antibiotics. Explanation of a micromethod].
July 1972, La Nouvelle presse medicale,
M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
[Sensitivity of Mycobacterium fortuitum by the broth microdilution method determining the inhibitory minimal concentration].
January 1992, Revista cubana de medicina tropical,
M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
A comparison of the Steenken minimal inhibitory concentration and the Canetti proportion methods for determining levels of drug resistance in cultures of Mycobacterium tuberculosis.
August 1968, The American review of respiratory disease,
M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
[Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
January 1988, Revue des maladies respiratoires,
M V Pontino, and B Di Giulio, and C Fernández, and B Imperiale, and A Bodon, and N Morcillo
[Penicillinase activity and minimal inhibitory concentration of betalactam antibiotics against mastatis staphylococci].
September 1978, Berliner und Munchener tierarztliche Wochenschrift,
Copied contents to your clipboard!